Patent · US Active

Assessment of abnormality regions associated with a disease from chest CT images

US11430121B2 · kind B2 · utility

1Cited by

3References

20Claims

0Family size

Assignee

Siemens Healthcare Limited · DE

Inventors

Shikha Chaganti · Nashville, US
Sasa Grbic · Plainsboro, US
Bogdan Georgescu · Plainsboro, US
Zhoubing Xu · Plainsboro, US
Siqi LIU · Dongguan, CN
Youngjin Yoo · Princeton, US
Thomas Re · Monroe, US
Guillaume Chabin · Paris, FR
Thomas Flohr · Uehlfeld, DE
Valentin Ziebandt · Nuremberg, DE
Dorin Comaniciu · Princeton Junction, US
Brian Teixeira · Lawrenceville, US
Sebastien Piat · Lawrence, US

Key dates

Filing date	Apr 1, 2020
Grant date	Aug 30, 2022
Priority date	—
Expiry date	May 1, 2040

Classification

Technology area (CPC G)Physics
CPC primaryG06T2207/30061
WIPO fieldComputer technology
WIPO sectorElectrical engineering

Abstract

Systems and methods for assessing a disease are provided. Medical imaging data of lungs of a patient is received. The lungs are segmented from the medical imaging data and abnormality regions associated with a disease are segmented from the medical imaging data. An assessment of the disease is determined based on the segmented lungs and the segmented abnormality regions. The disease may be COVID-19 (coronavirus disease 2019) or diseases, such as, e.g., SARS (severe acute respiratory syndrome), MERS (Middle East respiratory syndrome), or other types of viral and non-viral pneumonia.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.